Evaluation of Neutrophil Gelatinase-Associated Lipocalin and Cystatin C in Early Diagnosis of Chronic Kidney Disease in the Absence of the Gold Standard
Copyright© 2020, Galen Medical Journal..
BACKGROUND: Glomerular filtration rate (GFR) is considered as a gold standard of kidney function. However, using GFR as the gold standard is not common in clinical practice, because its direct measurement is usually expensive, cumbersome, and invasive. In the present study, we assessed the predictive power of two other biomarkers, Cystatin-C (Cys-C) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) for early detection of chronic kidney diseases (CKD) in the absence of a gold standard.
MATERIALS AND METHODS: In this study, 72 patients who referred to the Shohadaye Tajrish Hospital of Tehran, Iran, for measuring their kidney function were studied. The ELISA method was utilized for measuring plasma NGAL (PNGAL) and serum Cys-C (SCys-C). The Bayesian latent class modeling approach was applied to asses the predictive power of these biomarkers.
RESULTS: While both the biomarkers had rather high sensitivities (PNGAL=91%, SCys-C= 89%), the specificity of SCys-C biomarker was very lower than the one of PNGAL (SCys-C=56%, PNGAL=94%). The estimated area under the receiver operating characteristic (ROC) curve for SCys-C as the single biomarker for the diagnosis of CKD was about 0.76, while a similar estimate for PNGAL was 0.93. The added value of PNGAL to SCys-C for the diagnosis of CKD in terms of the ROC curve was about 0.19, while the added value of SCys-C to PNGAL was less than 0.02.
CONCLUSION: In general, our findings suggest that PNGAL can be utilized as a single reliable biomarker for early detection of CKD. In addition, results showed that when a perfect gold standard is not available, Bayesian approaches to latent class models could lead to more precise sensitivity and specificity estimates of imperfect tests.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Galen medical journal - 9(2020) vom: 01., Seite e1698 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Masaebi, Fatemeh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bayesian Approach |
|---|
| Anmerkungen: |
Date Revised 26.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.31661/gmj.v9i0.1698 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330092251 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330092251 | ||
| 003 | DE-627 | ||
| 005 | 20231225210540.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.31661/gmj.v9i0.1698 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1100.xml |
| 035 | |a (DE-627)NLM330092251 | ||
| 035 | |a (NLM)34466571 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Masaebi, Fatemeh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluation of Neutrophil Gelatinase-Associated Lipocalin and Cystatin C in Early Diagnosis of Chronic Kidney Disease in the Absence of the Gold Standard |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright© 2020, Galen Medical Journal. | ||
| 520 | |a BACKGROUND: Glomerular filtration rate (GFR) is considered as a gold standard of kidney function. However, using GFR as the gold standard is not common in clinical practice, because its direct measurement is usually expensive, cumbersome, and invasive. In the present study, we assessed the predictive power of two other biomarkers, Cystatin-C (Cys-C) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) for early detection of chronic kidney diseases (CKD) in the absence of a gold standard | ||
| 520 | |a MATERIALS AND METHODS: In this study, 72 patients who referred to the Shohadaye Tajrish Hospital of Tehran, Iran, for measuring their kidney function were studied. The ELISA method was utilized for measuring plasma NGAL (PNGAL) and serum Cys-C (SCys-C). The Bayesian latent class modeling approach was applied to asses the predictive power of these biomarkers | ||
| 520 | |a RESULTS: While both the biomarkers had rather high sensitivities (PNGAL=91%, SCys-C= 89%), the specificity of SCys-C biomarker was very lower than the one of PNGAL (SCys-C=56%, PNGAL=94%). The estimated area under the receiver operating characteristic (ROC) curve for SCys-C as the single biomarker for the diagnosis of CKD was about 0.76, while a similar estimate for PNGAL was 0.93. The added value of PNGAL to SCys-C for the diagnosis of CKD in terms of the ROC curve was about 0.19, while the added value of SCys-C to PNGAL was less than 0.02 | ||
| 520 | |a CONCLUSION: In general, our findings suggest that PNGAL can be utilized as a single reliable biomarker for early detection of CKD. In addition, results showed that when a perfect gold standard is not available, Bayesian approaches to latent class models could lead to more precise sensitivity and specificity estimates of imperfect tests | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bayesian Approach | |
| 650 | 4 | |a Chronic Kidney Diseases | |
| 650 | 4 | |a Cystatin C | |
| 650 | 4 | |a Latent Class Model | |
| 650 | 4 | |a Neutrophil Gelatinase-Associated Lipocalin | |
| 650 | 4 | |a Sensitivity | |
| 650 | 4 | |a Specificity | |
| 700 | 1 | |a Azizmohammad Looha, Mehdi |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Zhuoyu |e verfasserin |4 aut | |
| 700 | 1 | |a Zarean, Elaheh |e verfasserin |4 aut | |
| 700 | 1 | |a Nasiri, Malihe |e verfasserin |4 aut | |
| 700 | 1 | |a Kazerouni, Faranak |e verfasserin |4 aut | |
| 700 | 1 | |a Gharishvandi, Fatemeh |e verfasserin |4 aut | |
| 700 | 1 | |a Zayeri, Farid |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Galen medical journal |d 2018 |g 9(2020) vom: 01., Seite e1698 |w (DE-627)NLM330090666 |x 2322-2379 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2020 |g day:01 |g pages:e1698 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.31661/gmj.v9i0.1698 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2020 |b 01 |h e1698 | ||